Reagent case for lung carcinoma susceptibility detection through SNPs locus of XRCC1 gene and ERCC2 gene

A kit and susceptibility technology, applied in the field of kits for detecting susceptibility to lung cancer, can solve problems such as decreased repair ability, weakened transcription factor complex performance, and decreased transcription factor

Inactive Publication Date: 2008-03-12
XINBAXIANG SHANGHAI MOLECULAR MEDICAL TECH SHANGHAI
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

A number of current studies have shown that the polymorphism of this site will weaken the performance of the transcription factor complex that ERCC2 participates in, thereby reducing the ability to repair DNA damage, and the ability of transcription factors will also decrease at the same time, resulting in a series of Occurrence of diseases such as lung cancer, prostate cancer, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1. Use of detection kits

[0027] Step 1: Extraction of DNA template

[0028] Genomic DNA of oral epithelial cells was extracted by silica gel adsorption.

[0029] Step 2: Real-time quantitative PCR reaction

[0030] Use a fluorescent quantitative PCR detection kit that can detect susceptibility to lung cancer, which contains the following primer pairs and fluorescent probes:

[0031] Sense primer 1: 5'-TAACTGGCATCTTCACTTCT-3' (SEQ ID NO: 1) with a Tm value of 56°C

[0032] Antisense primer 1: 5'-TCCAGATTCCTGGCATTGC-3' (SEQ ID NO: 2) with a Tm value of 58°C

[0033] Sense primer 2: 5'-ATCAAAGAGACAGACGAGCA-3' (SEQ ID NO: 3) with a Tm value of 58°C

[0034] Antisense primer 2: 5'-TCAGGAAGCCCAGGAAAT-3' (SEQ ID NO: 4) with a Tm value of 54°C

[0035] Fluorescent probe 1: 5'-CGGCTGCCCTCCCAGAGG-3' (SEQ ID NO: 5) with a Tm value of 64°C

[0036] Fluorescent probe 2: 5'-TGCCCAACGAAGTGCTGCAG-3' (SEQ ID NO: 6) with a Tm value of 64°C

[0037] Sense primer 1, antisens...

Embodiment 2

[0042] Example 2. Services that guide people to proactively prevent lung cancer

[0043] At present, Shanghai Zhujian Bioengineering Co., Ltd. has launched this service.

[0044] Step 1: DNA Extraction

[0045] The subjects were consulted before the service, and the subjects signed the informed consent and filled out the questionnaire on living and eating habits. According to the instructions in the sampling box, the oral epithelial cells were sampled with oral swabs, and the DNA of the oral epithelial cells was extracted by silica gel adsorption.

[0046] Step 2: Genotyping Assays

[0047] Using the kit provided by the present invention, simultaneously perform fluorescent quantitative PCR detection on the SNP site rs25487 on the XRCC1 gene and the SNP site rs1799793 on the ERCC2 gene of the DNA of the subject to be tested, and determine the genotypes of the two SNPs sites.

[0048] Step 3: Instruct people to be proactive in preventing lung cancer

[0049] Through the anal...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a reagent box for detecting lung cancer susceptibility. The reagent box comprises a pair of specificity primers for detecting concurrently no. rs25487 SNP site of XRCC1 gene and no. rs1799793 SNP site of ERCC2 gene, a specificity fluorescent probe and an ordinary assembly for fluorescent quantitative PCR detection. The reagent box predicts the susceptibility of individuals on lung cancer by detecting and analyzing currently the type of carried gene at SNPs site of individual XRCC1 and ERCC2 gene.

Description

technical field [0001] The invention relates to a kit for detecting disease susceptibility, in particular to a kit for detecting susceptibility to lung cancer, through simultaneous detection of X-ray repair cross-complementing gene 1 (XRCC1) Single nucleotide polymorphism (SNP) sites and excision repair complex 2 (Excision Repair Cross-complementing Rodent Repair Deficiency, Complementation Group2, ERCC2) SNP sites to predict individual susceptibility to lung cancer . Background technique [0002] Primary bronchial lung cancer, referred to as lung cancer, is one of the most common malignant tumors in the world and a serious threat to human health and life. Tumor cells originate from the bronchial mucosa or glands, and often have regional lymph node and hematogenous metastasis. In the early stage, respiratory symptoms such as irritating cough and blood in the sputum are often present. The speed of disease progression is related to the biological characteristics of the cells....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
Inventor 冯哲民邹祖烨
Owner XINBAXIANG SHANGHAI MOLECULAR MEDICAL TECH SHANGHAI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap